Condition
Hepatocellular clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hepatocellular clinical trials that are recruiting, at sites in 2 countries (most in South Korea (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Carbon ion radiotherapy plus atezolizumab and bevacizumab for advanced hepatocellular carcinoma
This trial will try adding carbon ion radiotherapy to standard atezolizumab‑bevacizumab treatment for adults with advanced hepatocellular carcinoma to see if it controls tumors better and improves survival.
-
Using targeted radiation therapy for small liver cancer recurrence
This study is testing whether a special type of targeted radiation therapy can help people with small liver cancer that has come back after surgery or other treatments.
Related topics
Quick answers
How many Hepatocellular clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.